Brief: Organogenesis Q3 Revenue USD 115.2 Million
12/11/2024 21:05
Nov 12 (Reuters) - Organogenesis Q3 net income USD 12.3 million. * Q3 adjusted net income USD 12.9 million * Q3 adjusted EBITDA USD 13.4 million * Q3 operating income USD 6.2 million * outlook FY EBITDA USD 14.4 million * outlook FY adjusted EBITDA USD 31.7-47.4 million
Recent news on Organogenesis Holdings
See all newsBrief: Organogenesis Announces Publication Of Peer-Reviewed Prepare Trial Results
Organogenesis Holdings Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Organogenesis Q2 Net Product Revenue USD 42.8 Million
Organogenesis Holdings Inc. expected to post a loss of 35 cents a share - Earnings Preview
Brief: Organogenesis Announces Publication Of Peer-Reviewed Clinical Trial Results Demonstrating Clinical Benefit Of Affinity™ In The Most Challenging And Complex Venous Leg Ulcers